GLPG1690
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for GLPG1690, covering 2015-09-22 to 2022-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care [Phase 3]